Bumpus Namandje bought RXRX
March 17, 2025 · Form 4 insider transaction
Bumpus Namandje bought 36,549 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
36,549
Price
$0.00
Total value
N/A
InsiderBumpus Namandje
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateMarch 17, 2025
Filing dateMarch 19, 2025
Shares owned after36,549
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of March 17, 2025, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates.